[$$] Lilly, Bristol-Myers Post Increased Profits (at The Wall Street Journal Online)

yahoo.com     Jul 25, 2008            

Word Count: 440 | Companies Featured in This Article: Eli Lilly, Bristol-Myers Squibb, Daiichi Sankyo, AstraZeneca, Sanofi-Aventis Eli Lilly & Co. and Bristol-Myers Squibb Co. reported improved second-quarter profits, helped by higher sales of drugs that treat cancer, mental illness and cardiovascular disease. The drug makers' results also were bolstered by cost cuts and favorable currency-exchange rates -- trends that are aiding profits throughout the industry at a time when large pharmaceutical companies are under pressure from generic competition and other challenges. Bristol-Myers disclosed plans for additional cost savings in coming years. In 4 p.m. composite trading on the New York Stock Exchange, Lilly's shares... [read full story]                    

Full Coverage

Bristol-Myers reports higher second-quarter profit

marketwatch.com     Jul 24, 2008          

BOSTON (MarketWatch) --- Bristol-Myers Squibb reported higher second-quarter earnings early Thursday, due largely to a 16% boost in sales. The drugmaker posted net income of $764 million, or 38 cents a share, compared with $706...                    

comments

Strong drug sales boost Bristol-Myers

marketwatch.com     Jul 24, 2008          

By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) - Bristol-Myers Squibb reported on Thursday that second-quarter earnings rose 8.2%, boosted by strong sales of drugs including Plavix, Abilify and Reyataz. Profit from...                    

comments

Strong drug sales boost Bristol-Myers (at MarketWatch)

yahoo.com     Jul 24, 2008          

By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) - Bristol-Myers Squibb reported on Thursday that second-quarter earnings rose 8.2%, boosted by strong sales of drugs including Plavix, Abilify and Reyataz. Profit from...                    

comments

[$$] Solid Sales Growth Boosts Profit at Lilly, Bristol-Myers (at The Wall Street Journal Online)

yahoo.com     Jul 24, 2008          

Word Count: 886 | Companies Featured in This Article: Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Sanofi-Aventis Eli Lilly & Co. and Bristol-Myers Squibb Co. reported improved second-quarter profits, helped by increased sales...                    

comments

                   

Bristol-Myers, Eli Lilly post strong 2Q results

wtop.com     Jul 24, 2008          

By LINDA A. JOHNSON AP Business Writer TRENTON, N.J. (AP) - At Bristol-Myers, Chief Executive Officer James Cornelius, who took over in September 2006, told analysts during a conference call that the company is doing a good job...                    

comments

                   

Bristol-Myers, Eli Lilly post strong 2Q results, but Wall Street still wait-and-see on stocks

startribune.com     Jul 24, 2008          

By LINDA A. JOHNSON , Associated Press TRENTON, N.J. - At Bristol-Myers, Chief Executive Officer James Cornelius, who took over in September 2006, told analysts during a conference call that the company is doing a good job...                    

comments

                   

Bristol-Myers, Eli Lilly post strong 2Q results

nwsource.com     Jul 24, 2008          

TRENTON, N.J. -- Like other major drugmakers, Bristol-Myers Squibb Co. and Eli Lilly & Co. saw benefits from the weak dollar in the second quarter, as sales grew at a faster rate overseas, but both also posted improvements in...                    

comments

                   

Bristol-Myers, Eli Lilly post strong 2Q results

examiner.com     Jul 24, 2008          

Like other major drugmakers, Bristol-Myers Squibb Co. and Eli Lilly & Co. saw benefits from the weak dollar in the second quarter, as sales grew at a faster rate overseas, but both also posted improvements in their U.S....                    

comments

                   

Bristol-Myers, Eli Lilly post strong 2Q results

ibtimes.com     Jul 24, 2008          

Like other major drugmakers, Bristol-Myers Squibb Co. and Eli Lilly & Co. saw benefits from the weak dollar in the second quarter, as sales grew at a faster rate overseas, but both also posted improvements in their U.S....                    

comments

                   

Bristol-Myers, Eli Lilly post strong 2Q results (AP)

yahoo.com     Jul 24, 2008          

AP - Like other major drugmakers, Bristol-Myers Squibb Co. and Eli Lilly & Co. saw benefits from the weak dollar in the second quarter, as sales grew at a faster rate overseas, but both also posted improvements in their U.S....                    

comments

1 2 next